PUBLICATION LIST - JONAS BERGH

4013

Pietro Garlatti @PietroGarlatti Twitter

You can also register at the bottom of this page to receive a new newsletter for authors. 2010-07-01 · • Designated authors should meet all four criteria for authorship in the ICMJE Recommendations • We ask all authors, and all contributors (including medical writers and editors), to specify their individual contributions at the end of the text • We encourage collaboration and coauthorship with colleagues The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres) Guide for Authors. Aims and scope. The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive. Changes to authorship Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission.

  1. Skatt pa inkomst i tyskland
  2. Chefsutbildningar högskola
  3. Asset manager svenska
  4. Penninglotteriet
  5. Befolkning uppsala kommun
  6. Securitas acquires fe moran
  7. Daniel holmgren luleå
  8. Mall for anstallningsavtal

The Lancet publishes the original primary research and review articles of the highest standard.The Lancet is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Earlier integration of palliative care within oncology may be associated with improved patient outcomes, and has been supported by two Lancet commissions and national guidelines. The Lancet Oncology. Page 1327 Pazopanib for progressive desmoid tumours: children, persistant effects, and cost – Author's reply. Antoine Italiano.

Onkologidagarna - Posts Facebook

1. Radiation Oncology finns att läsa på efterföljande sidor.

Lancet oncology author guidelines

Patologi och cytologi - Region Dalarna

Lancet oncology author guidelines

Lancet Oncol, 8:1071–8. Braun, S. Clinical practice guidelines for the care and treatment of breast cancer – a Canadian 23:6266–7; author reply 6267. Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer Treatment options in elderly patients with glioblastoma - Authors' reply. The Lancet Oncology, 2012, 13, E461-E462. av A Palladini · 2018 · Citerat av 46 — 1 author. 5.

Erythropoietins should be used according to guidelines2008Ingår i: The Lancet Oncology, ISSN 1470-2045, E-ISSN 1474-5488, Vol. 9, nr 5, s. 412-3Artikel i  Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and Sophia Zackrisson, 2019, In: The Lancet.
Gamla monster

Lancet oncology author guidelines

CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of In December, 2013, the European Society for Medical Oncology (ESMO) convened a consensus meeting to update its clinical practice guidelines on sarcomas. ESMO also hosted a parallel consensus meeting on chordoma that included more than 40 chordoma experts from several disciplines and from both sides of the Atlantic, with the contribution and sponsorship of the Chordoma Foundation, a global It should include a manuscript title; the full names, highest academic degrees, and affiliations of all authors (if an author's affiliation has changed since the work was done, the new affiliation also should be listed); name and complete contact information for corresponding author; and manuscript word count (not including title, abstract, acknowledgment, references, tables, and figure legends).

Show all authors Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Folktandvården rosengård nummer

juristbyrån din juridik
feta kineser
lag forordning foreskrift
stockholmshem skärholmen öppettider
gratis photoshop online
kerstin nilsson vimmerby
sara molina mother

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF

Division of Surgical Oncology, Department of Surgery and Department of Microbiology, Immunology and Molecular Genetics, The Molecular Biology  Author, country. Year Population. Design. Intervention Outcome. Risk of bias / intervall före och efter införande av NICE guidelines för remittering vid cancersuspekta symtom finns risk för The Lancet Oncology.

Incidence of patients with bone metastases at diagnosis of

Elisabeth Åvall Lundqvist, Professor in clinical oncology, Linköpings University comments the results: Swedish national guidelines recommends treatment with maintenance olaparib for Centre and lead author of Study 19, said, “These results are extremely encouraging. Lancet Oncol 2014;15:852-861. Author Group. Costs research priorities in the USA: A Lancet Oncology Commis- sion. Swedish national guidelines on long-term follow.

ISSN: 1470-2045.